期刊文献+

8 431株病原菌的分布及耐药性分析 被引量:2

Distribution and Drug Resistance of 8 431 Pathogen Strains
下载PDF
导出
摘要 目的了解感染性疾病病原菌分布及常见病原菌的耐药情况。方法对本院2010-01-2012—12住院患者8431株病原菌的分布及耐药性分析。结果共分离病原菌8431株,其中革兰阳性(G+)菌1787株,占21.2%;革兰阴性(G-)菌6231株,占73.9%;主要包括大肠埃希菌(23.6%)、肺炎克雷伯菌(18.4%)、鲍曼不动杆菌(11.60%)、金黄色葡萄球菌(10.3%)等;药敏试验结果显示,所分离的G’菌对万古霉素、利奈唑胺最敏感,对呋喃妥因、利福平敏感性较好,对其他抗菌药物敏感性不佳,G-菌对亚胺培南、美洛培南高度敏感,对哌拉西林/他唑巴坦、头孢哌酮/舒巴坦和阿米卡星也较敏感。结论临床应重视病原学检查,开展细菌耐药性监测,合理使用抗菌药物。 Objective To determine the distribution of infectious disease pathogens and druG-resistance of common pathogenic bacteria. Methods A total of 8 431 samples from patients in the hospital since Jan. 2010 to Dec. 2012 were collected, and the distribution and drug resistance of pathogenic bacteria was identified. Results Totally 8 431 strains were isolated, in which Gram-positive ( G~ ) bacteria were 1 787 (21.2%) ; while Gram-negative ( G- ) bacteria were 6 231 ( 73. 9% ). Most of them were Escherichia coli ( 23. 6% ), Klebsiella pneumoniae ( 18. 4% ), Bauman Acinetobacter (11.60%), Staphylococcus aureus (10.3%), etc. The result of drug sensitivity test showed that the isolated G ~ bacteria were most sensitive to vancomycin, linezolid; and well sensitive to nitrofurantoin and rifampin, while poorly sensitive to other antimicrobial. G- bacteria were highly sensitive to imipenem, meropenem; while were sensitive to piperacillin/tazobactam, cefoperazone/sulbactam and Amikacin. Conclusion It is suggested that there be urgent need for surveillance of bacterial resistance and rational use of antimicrobial agents be emphasized.
出处 《今日药学》 CAS 2013年第11期767-770,共4页 Pharmacy Today
关键词 抗菌药物 耐药性 病原菌 antimicrobial drugs drug resistance pathogen
  • 相关文献

参考文献5

二级参考文献56

  • 1王伟洪,何建方,施柏年,沈翠芬,王萍,童照威,张晓祥.2547株肠球菌分布特征及耐药谱变迁[J].中华临床感染病杂志,2008,1(3). 被引量:4
  • 2李家泰,李耘,齐慧敏,代表中国细菌耐药监测研究组.2002—2003年中国革兰阴性细菌耐药性监测研究[J].中华检验医学杂志,2005,28(1):19-29. 被引量:296
  • 3王艳,高灵宝,徐祖龙.临床革兰阴性菌的分布及耐药性变迁[J].中国医院药学杂志,2006,26(3):343-344. 被引量:6
  • 4Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; nineteeth informational supplement. Wayne: Clinical and Laboratory Standards Institute. 2009.
  • 5Michael J, Dowzicky MS, Choong H. Park, update on antimicrobial susceptibility rates among gram negative and gram - positive organisms in the United States:Results from the tigecycline evaluation and surveillance trial (TEST) 2005 to 2007 [ J ]. Clin Therapeut, 2008; 30 : 2040 - 2050.
  • 6朱德妹.2005年中国CHINET葡萄球菌属耐药性分析[J].中国感染与化疗杂志,2007,7(4):269-273. 被引量:73
  • 7Peleg AY, Seifert H, Paterson DLAeinetobaeter baumannii: emergence of a successful pathogen. Clin Micmbiol Rev,2008,21 : 538-582.
  • 8Falagas ME, Koletsi PK, Bliziotis IA.The diversity of definitions of muhidrug-resistant(MDR) and pandrug-resistant (PDR) Aeinetohaeter bsumannli and Pseudomonas aeruginosa.J Med Microbiol, 2006,55: 1619-1629.
  • 9Paterson DL, Doi Y.A step closer to extreme drug resistance(XDR) in gram-negative bacilli.Clin Infect Dis,2007,45: 1179-1181.
  • 10Falagas ME, Karageorgopoulos DE.Pandrug resistance(PDR), extensive drug resistance(XDR), and muhidrug resistance(MDR) among Gram- negative bacilli: need for international harmonization in terminology.Clin Infect Dis, 2008,46: 1121-1122; author reply 1122.

共引文献538

同被引文献18

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部